Thiodigalactoside

DB04396ExperimentalSmall molecule

Thiodigalactoside is a solid. This compound belongs to the dihexoses. These are disaccharides containing two hexose carbohydrates. This medication is known to target galectin-1, heat-labile enterotoxin b chain, neurocan core...

Formula / weight: C₁₂H₂₂O₁₀S · 358.362 g/mol (avg)

Resolves to

Compound

CAS51555-87-4ChEMBLCHEMBL52011PubChem119138

Structure

InChIKeySYKYBMOFPMXDRQ-ZFDCCPEWSA-NSMILES

[H][C@]1(CO)O[C@@]([H])(S[C@]2([H])O[C@]([H])(CO)[C@]([H])(O)[C@]([H])(O)[C@@]2([H])O)[C@]([H])(O)[C@@]([H])(O)[C@@]1([H])O

Targets

P32890eltBP02920lacYO14594NCANP09382LGALS1

What you can answer from here — as of August 31, 2026

4Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

6+ReferencesStructured and connected to the statements they support

Which drugs share a target with Thiodigalactoside, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account